Dose dependency of sodium alginate oligosaccharides in a randomized double-blind placebo-controlled clinical study in subjects with high normal blood pressure and mild hypertension

Japanese Pharmacology and Therapeutics

Volumn 34, Issue 11, 2006, Pages 1267-1277

  Chaki, Takamitsu ^a   Amano, Hiroyuki ^b   Kajimoto, Osami ^c   Baba, Takashi ^a  

^a Maruha Nichiro Holdings Inc   (Japan)

^b Soiken Inc   (Japan)

^c Osaka University of Foreign Studies   (Japan)

Author keywords

Antihypertensive effect; Clinical trial; Dose dependency; Sodium alginate oligosaccharides

Indexed keywords

LACTOSE; OLIGOSACCHARIDE; PLACEBO; SODIUM ALGINATE OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; COMMON COLD; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; FEMALE; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 33846045755     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ministry of health, labour and welfare. National nutrition survey; 1999.
2. Matsui T, Kawasaki T. Antihypertensive effects of bioactive peptides derived from food protein. J Jpn Soc Nutr Food Sci 2000; 53: 77-85.
3. Kajimoto O, Seki E, Osajima K, Matsui T, Matsumoto K, Osajima Y, et al. Hypotensive effects of food containing peptide derived from sardine muscle hydrolyzate, in subjects with high-normal, or hypertension. J Nutr Food 2003; 6: 65-82.
4. Kajimoto O, Seki E, Osajima K, Toda H, Matsui T, Matsumoto K, et al. Hypotensive effects of the tablets containing peptide derived from sardine muscle hydrolyzate, in subjects with high-normal, or hypertension. J Nutr Food 2003; 6: 83-98.
5. Saito M, Takahashi T, Hagino H. Antihypertensive effect of the oligo peptides derived from Nori (Porphyra yezoensis) on volunteers with mild and moderate hypertension. Jpn Soc Clinical Nutr 2002; 24: 30-7.
6. Kajimoto O, Saito M, Hagino H, Sakamoto A, Hirata H. Hypotensive effect and safety of the granular foods containing oligo peptides derived from Nori (Porphyra yezoensis) in subjects with high-normal blood pressure and mild hypertension. Health Sci 2004; 20: 91-102.
7. Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by a cell-wall proteinase from Lactobaacillus helveticus CP790. J Dairy Sci 1994; 77: 917-22.
8. Yamamoto N, Akino A, Takano T. Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci Biotech Biochem 1994; 58: 776-8.
9. Nakamura Y, Yamamoto N, Sakai K, Takano T. Antihypertensive effects of sour milk and peptides isolated from that are inhibitors to angiotensin I-converting enzyme. J Dairy Sci 1995; 78: 1253-7.
10. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y. A placebo-controlled study of the effects of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996; 64: 767-71.
11. Kawasaki T, Uezono K, Nakazawa Y. Antihypertensive Mechanism of food for specified health use; "Eucommia leaf glycoside" and its clinical application. J Health Sci 2000; 22: 29-36.
12. Kajimoto O, Hirata H, Nishimura A. Hypotensive action of novel fermented milk containing γ-aminobutyric acid (GABA) in subjects with mild or moderate hypertension. J Nutr Food 2003; 6: 51-64.
13. Kimura M, Hayakawa K, Sansawa H. Involvement of γ-aminobutyric acid (GABA) B receptors in the hypotensive effect of systemically administered GABA in spontaneously hypertensive rats. Jpn J Pharmacol 2002; 89: 388-94.
14. Hayakawa K, Kimura M, Kamata K. Mechanism underlying γ-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur J Pharmacol 2002; 428: 107-13.
15. Suzuki I, editor. Fact about food additives. 6th ed. Hirokawa Book Store; 1992.
16. Zhang Z, Yu G, Guan H, Zhao X, Du Y, Jiang X. Preparation and structural elucidation of alginate oligosaccharides degraded by alginate lyase from Vibro sp. 510. Carbohydr Res 2004; 339: 1475-81.
17. Tsuji K, Tsuji E, Nakagawa Y, late Suzuki S. Effects of Na-binding capacity of dietary fibers on blood pressure in spontaneously hypertensive rats. Jpn Soc Home Econ 1988; 39: 187-95.
18. Akiyama H, Endo T, Nakakita R, Murata K, Yonemoto Y, Okayama K. Effect of depolymerized alginates on the growth of bifidobacteria. Biosci Biotechnol Biochem 1992; 56: 355-6.
19. Yonemoto Y, Tanaka H, Yamashita T, Kitabatake N, Ishida Y, Kimura A, et. al. Promotion of germination and shoot elongation of some plants by alginate oligomers prepared with bacterial alginate lyase. J Biosci Bioeng 1993; 75: 68-70.
20. Yoshida T, Hirano A, Wada H, Takahashi K, Hattori M. Alginic acid oligosaccharide suppresses Th2 development and IgE production by inducing IL-12 production. Int Arch Allergy Immunol 2004; 133: 239-47.
21. New Food Creation Technical Research Union Functional creation · regulatory technique for food materials. Approach for a New Food Material; 1999.
22. Kawada A, Hiura N, Shiraiwa M, Tajima S, Hiruma M, Hara K, et al. Stimulation of human keratinocyte growth by alginate oligosaccharides, a possible co-factor for epidermal growth in cell culture. FEBS Letters 1997; 408: 43-6.
23. Hiura N, Chaki T, Ogawa H. Antihypertensive effects of sodium alginate oligosaccharides. Nippon Nõgeikagaku Kaishi 2001; 75: 783-5.
24. Tsuchida T, Chaki T, Hiura N, Satou R. Effect of sodium alginate oligosaccharide on human blood pressure. Med Cons New-Remed 2001; 38: 555-60.
25. Chaki T, Nishimoto S, Hiura N, Satou R, Tou Y, Kakinuma S. Effect of a powdered drink containing sodium alginate oligosaccharide on blood pressure in mild hypertensive and high normal blood pressure subjects. J Nutr Food 2002; 5: 41-54.
26. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clinical and experimental hypertension. Clin Exp Hypertens 1999; 21: 1009-60.